The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1356
ISSUE 1356
January 24, 2011
Issue 1356
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Ceftaroline Fosamil (Teflaro) - A New IV Cephalosporin
January 24, 2011 (Issue: 1356)
The FDA has approved ceftaroline fosamil (Teflaro –
Forest), an intravenous (IV) cephalosporin, for treatment
of acute bacterial skin and skin structure infections,
including those caused by methicillin-resistant
Staphylococcus aureus (MRSA),...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.